People Otto Boerman

Contact

Otto Boerman PhD

+31 (0)24 361 35 77
contact

Otto Boerman full professor

In 2007 Otto Boerman became a full professor in Radiochemistry at the Radboud University Nijmegen.

read more

Otto Boerman full professor

Otto C. Boerman (Lochem, 25 May 1959, H-index: 56) studied Chemistry at the University of Nijmegen (1977-1884). From 1985 until 1990, he was a junior investigator at the Department of Cell Biology at the University of Nijmegen, where he wrote his thesis, entitled ‘Development and Application of Monoclonal Antibodies Against Ovarian Carcinoma-Associated Antigens.’ As a fellow of the Dutch Cancer Society he worked at the Center for Molecular Medicine and Immunology in Newark, NJ (1990-1991) on targeting cancer with radiolabeled monoclonal antibodies (Head: Dr. D.M. Goldenberg). He then worked at the Biological Response Modifiers Program of the National Institutes of Health in Frederick, MD (1991-1992) on the in vivo effects of IL-7 (Head: Dr. D. Longo). When he returned to The Netherlands in 1992, he started his preclinical research group at the Department of Nuclear Medicine of the Radboud University Nijmegen Medical Center. In his group preclinical research focuses on radionuclide imaging and radionuclide therapy with radiolabeled antibodies and peptides In 2007 he became a full professor in Radiochemistry at the Radboud University Nijmegen. Prof.dr. Otto C. Boerman is a member of the editorial board of The Journal of Nuclear Medicine (JNM), The European Journal of Nuclear Medicine, Molecular Imaging (EJNMMI), Cancer, Biotherapy and Radiopharmaceuticals (CB&R), Frontiers in Nuclear Medicine and The American Journal of Nuclear Medicine and Molecular Imaging (AJNMMI). He was (co-)promoter of 35 PhD candidates. He is a (co-)author of more than 450 peer reviewed scientific publications. In 2017 he was appointed as director of the Central Facility for Animal Research (CDL) of the Radboud University Nijmegen.

Personal prizes & awards national & international

  • 2014: Best basic science paper in European Urology
  • 2011: Woldring Prize (Dutch Society of Nuclear Medicine, NVNG) for the best Dutch PhD-thesis in nuclear medicine 2010
read more

Personal prizes & awards national & international

  • 2014: Best basic science paper in Eur Urol. Muselaers CH, Boerman OC, Oosterwijk E, Langenhuijsen JF, Oyen WJ, Mulders PF. Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma. Eur Urol. 2013;63:1101-1106
  • 2011: Woldring Prize (Dutch Society of Nuclear Medicine, NVNG) for the best Dutch PhD-thesis in nuclear medicine 2010 “Adjuvant radioimmunotherapy in experimental colorectal cancer” by Dr.G.M. de Jong (promotor)
  • 2011: Marie Curie Award (European Association of Nuclear Medicine) for “Longitudinal imaging of transplanted islets in a rat model with SPECT”
  • 2011: EANM Springer Prize for Most Cited Paper 2010. (European Association of Nuclear Medicine) for the manuscript by Dijkgraaf et al., Improved targeting of the αvβ3 integrin by multimerisation of RGD peptides. European Journal of Nuclear Medicine and Molecular Imaging 2007; 34: 267-273 (group)
  • 2000: Best basic science paper in Journal of Nuclear Medicine. Steffens MG, Oosterwijk E, Kranenborg MH, Manders JM, Debruyne FM, Corstens FH, Boerman OC. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. J Nucl Med. 1999;40:829-836
  • 1999: Jean Debiesse Award (European Association of Nuclear Medicine) for “Infectious and inflammatory disease imaging with labeled liposomes” (group)
  • 1997: Jean Debiesse Award (European Association of Nuclear Medicine) for “Infectious and inflammatory disease imaging with labeled Interleukins” 
  • 1997: Amersham Health Care Award (International Society Of Radiolabeled Blood Elements) for “Infectious and inflammatory disease imaging with labeled Interleukins” (group)
  • 1994: Marie Curie Award (European Association of Nuclear Medicine) for “Infectious and inflammatory disease imaging with labeled Interleukins” 

Field of study

Radiology & Nuclear Medicine

Radboudumc Technology Center Animal research facility

This technology center offers advice and support from planning up to and including the conduct of animal research on behalf of biomedical research and education.

read more

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more